摘要
目的:观察小剂量HAG方案治疗骨髓增生异常综合征转化的急性髓性白血病(MDS/AML)的临床效果。方法:采用LD-HA+G-CSF方案治疗17例MDS/AML患者。结果:6例(35.3%)完全缓解,4例(23.5%)部分缓解,有效率为58.8%,无一例早期死亡。结论:HAG方案对MDS/AML疗效较好,不良反应小。
Objective：To observe the clinical effect of LD-HA and G-CSF on treatment of MDS/ AML patients. Methods： Seventeen MDS/AML patients were treated with LD-HA and G-CSF. Results： Ten of 17 patients achieved completed rernission（CR）, and 4 patients achieved partial remission（PR）;the total remission rate was 58.8%. Conclusion： The chemotherapy of LD-HA and G-CSF is safe and effective in the treatment of MDS/AML.
出处
《实用临床医学（江西）》
CAS
2007年第3期23-24,共2页
Practical Clinical Medicine
关键词
骨髓增生异常综合征
转化
白血病
化疗
myelodysplastic syndrome
transformation
leukemia
chemotherapy
